Literature DB >> 18353329

A study of visuospatial working memory pre- and post-Gonadotropin Hormone Releasing Hormone agonists (GnRHa) in young women.

Michael C Craig1, Paul C Fletcher, Eileen M Daly, Marco M Picchioni, Mick Brammer, Vincent Giampietro, Janice Rymer, Philip K McGuire, Pauline M Maki, Declan G M Murphy.   

Abstract

Gonadotropin Hormone Releasing Hormone agonists (GnRHa) produce an acute decline in ovarian hormone production leading to a 'pseudo' menopause. This is therapeutically useful in the management of a variety of gynaecological conditions but also serves as a powerful model to study the effects of ovarian hormones on cognition. Animal and human behavioral studies report that memory is particularly sensitive to the effects ovarian hormone suppression (e.g. post GnRHa). Further, it has recently been reported that ovariectomy in young women increases the risk of cognitive impairment in later life. However, the underlying brain networks and/or stages of memory processing that might be modulated by acute ovarian hormone suppression remain poorly understood. We used event-related fMRI to examine the effect of GnRHa on visual working memory (VWM). Neuroimaging outcomes from 17 pre-menopausal healthy women were assessed at baseline and 8 weeks after GnRHa treatment. Seventeen matched wait-listed volunteers served as the control group and were assessed at similar intervals during the late follicular phase of the menstrual cycle. We report GnRHa was associated with attenuation of left parahippocampal (BA 35) and middle temporal gyri (BA 21 ,22, 39) activation, with a significant group-by-time interaction at left precuneus (BA 7) and posterior cingulate cortex (PCC) (BA 31) at encoding, and with cerebellar activation at recognition in the context of unimpaired behavioral responses. Our study suggests that acute ovarian hormone withdrawal following GnRHa, and perhaps at other times, (e.g. following surgical menopause and postpartum) alters the neural circuitry underlying performance of VWM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353329     DOI: 10.1016/j.yhbeh.2008.01.012

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  11 in total

1.  Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Sex differences in visuospatial abilities persist during induced hypogonadism.

Authors:  Gioia M Guerrieri; Paul G Wakim; P A Keenan; Linda A Schenkel; Kate Berlin; Carolyn J Gibson; David R Rubinow; Peter J Schmidt
Journal:  Neuropsychologia       Date:  2015-12-21       Impact factor: 3.139

Review 3.  Uterine fibroids and current clinical challenges.

Authors:  Salama S Salama; Gökhan S Kılıç
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-03-01

Review 4.  Determining menstrual phase in human biobehavioral research: A review with recommendations.

Authors:  Alicia M Allen; Aimee L McRae-Clark; Samantha Carlson; Michael E Saladin; Kevin M Gray; Cora Lee Wetherington; Sherry A McKee; Sharon S Allen
Journal:  Exp Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.157

Review 5.  Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary-reproductive axis.

Authors:  D C Skinner; A J Albertson; A Navratil; A Smith; M Mignot; H Talbott; N Scanlan-Blake
Journal:  J Neuroendocrinol       Date:  2009-03       Impact factor: 3.627

Review 6.  Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice.

Authors:  Franca Fruzzetti; Tiziana Fidecicchi
Journal:  Clin Drug Investig       Date:  2020-12       Impact factor: 2.859

7.  Cognitive performance in healthy women during induced hypogonadism and ovarian steroid addback.

Authors:  Peter J Schmidt; P A Keenan; Linda A Schenkel; Kate Berlin; Carolyn Gibson; David R Rubinow
Journal:  Arch Womens Ment Health       Date:  2012-11-28       Impact factor: 3.633

8.  Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates.

Authors:  Susan K Conroy; Brenna C McDonald; Tim A Ahles; John D West; Andrew J Saykin
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

Review 9.  Functional and molecular neuroimaging of menopause and hormone replacement therapy.

Authors:  Erika Comasco; Vibe G Frokjaer; Inger Sundström-Poromaa
Journal:  Front Neurosci       Date:  2014-12-08       Impact factor: 4.677

Review 10.  Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?

Authors:  Carlos G Martínez-Moreno; Denisse Calderón-Vallejo; Steve Harvey; Carlos Arámburo; José Luis Quintanar
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.